“Terry McAuliffe proposes … increasing the current limit on investment tax credits for commercialization. The current limit of $5 million dollars … should be increased by an amount between $1 million to $2.5 million depending on budget conditions, with the increase specifically targeted to biotechnology and biomedical companies.”